• 제목/요약/키워드: Non-clinical testing

검색결과 114건 처리시간 0.022초

Distribution Analysis of Candida albicans according to Sex and Age in Clinical Specimen Testing for Sexually Transmitted Diseases

  • Jae Eun Choi;Jae-Sik Jeon;Jae Kyung Kim
    • Journal of Microbiology and Biotechnology
    • /
    • 제33권1호
    • /
    • pp.123-126
    • /
    • 2023
  • The prevalence of candidiasis, a contagious disease with high morbidity and mortality, has sharply increased globally over the last two decades. Candida albicans can cause serious infections in patients with weak immunity and in recipients of prolonged antibiotic treatment. Consequently, rapid and accurate identification of species can play an important role in the treatment of candidiasis. Here, we investigated the positive rate and infection trend of C. albicans according to age, specimen type, and sex using multiplex real-time polymerase chain reaction-based testing of samples collected for the diagnosis of sexually transmitted diseases in Korea between 2018 and 2020. When the type of specimen collected was a swab, the positive rate of C. albicans was higher among younger women, and tended to decrease with age. Analysis of swab samples revealed higher positive rates than urinalysis. The reduction trend in positive rates by age was comparable between the overall samples and urine specimens. Among male patients, the positive rate did not differ substantially across the various types of specimens collected. Previous studies have shown a higher prevalence of non-albicans Candida species than C. albicans in clinical specimens, and exclusion of the former from our analysis may be a limitation of this study. However, our findings contribute significantly to the literature because globally, there is a paucity of epidemiological studies using molecular techniques to detect C. albicans in sexually transmitted disease test samples.

목 및 가슴신경뿌리병증의 임상적 고찰: 비침습적 중재시술치료 (Clinical Characteristics of Cervical and Thoracic Radiculopathies: Non-Invasive Interventional Therapy)

  • 노학재;이상헌;김병조
    • Annals of Clinical Neurophysiology
    • /
    • 제10권2호
    • /
    • pp.83-97
    • /
    • 2008
  • Cervical and thoracic radiculopathies are among the most common causes of neck pain. The most common causes are cervical disc herniation and cervical spondylosis in patients with cervical radiculopathy, and diabetes mellitus and thoracic disc herniation in thoracic radiculopathy. A thorough history, physical examination, and testing that includes electrodiagnostic examination and imaging studies may distinguish radiculopathy from other pain sources. Although various electrodiagnostic examinations may help evaluate radiculopathy, needle electromyography is the most important, sensitive, and specific method. Outcome studies of conservative treatments have shown varying results and have not been well controlled or systematic. When legitimate incapacitating symptoms continue despite conservative treatment attempts, more invasive spinal procedures and intradiscal treatment may be appropriate. Surgery has been shown to have excellent clinical outcomes in patients with disc extrusion and neurological deficits. However, patients with minimal disc herniation have fair or poor surgical outcomes. In addition, conventional open disc surgery entails various inadvertent surgical related risks. Although there has not yet been a non-surgical interventional procedure developed with the therapeutic efficacy of open surgery, conservative procedures can offer substantial benefits, are less invasive, and avoid surgical complications. While more invasive procedures may be appropriate when conservative treatment fails, prospective studies evaluating cervical and thoracic radiculopathies treatment options would help guide practitioners toward optimally cost-effective patient evaluation and care.

  • PDF

국내 허가사항에 반영된 약물 유전정보 분석 (Analysis of Pharmacogenetic Information in Korea Drug Labels)

  • 이미진;김수경;이정;곽혜선;최경희
    • 한국임상약학회지
    • /
    • 제31권1호
    • /
    • pp.21-26
    • /
    • 2021
  • Background: Pharmacogenomics is the study of how genetic mutations in patients affect their response to drugs. Pharmacogenomic studies aim to maximize drug effects and minimize adverse drug events. The Food and Drug Administration and the European Medicine Agency published guidelines for pharmacogenetics in 2005 and 2006, respectively; the Korean Ministry of Food and Drug Safety followed suit in 2015. Methods: This study analyzed pharmacogenomic information in the Korean Ministry of Food and Drug Safety's integrated drug information system to evaluate whether domestic pharmaceutical products reflect the current research on pharmacogenomic differences. Results: In June 2020, the Korean pharmacogenomic database contained genomic data on 90 compounds. Of these, 45 compounds were classified as "Antineoplastic and immunomodulating agents." The other 45 non-antineoplastic agents were in the following categories: Anti-infectives, Mental & behavior disorder, Hormone & metabolism related diseases, Cardiovascular system, Skin & subcutaneous tissue disease, Genito-urinary system and sex hormones, Blood and blood forming organs, Nervous system, Alimentary tract and metabolism, Musculo-skeletal system, and Other conditions including the respiratory system. In addition, 30 additives unrelated to the main ingredient were associated with genetic precautions. Conclusion: This study showed that antineoplastic and immunomodulating agents accounted for half the drugs associated with pharmacogenetic information. For antitumor and immunomodulatory drugs, genomic tests were recommended depending on the indication; this was in contrast to genomic testing recommendations for non-antineoplastic medications. Genomic tests were rarely requested or recommended for non-antineoplastic medications because the relationships between genotype and efficacy among those drugs were relatively weak.

Pulmonary Tuberculosis Diagnosis: Where We Are?

  • Leylabadlo, Hamed Ebrahimzadeh;Kafil, Hossein Samadi;Yousefi, Mehdi;Aghazadeh, Mohammad;Asgharzadeh, Mohammad
    • Tuberculosis and Respiratory Diseases
    • /
    • 제79권3호
    • /
    • pp.134-142
    • /
    • 2016
  • In recent years, in spite of medical advancement, tuberculosis (TB) remains a worldwide health problem. Although many laboratory methods have been developed to expedite the diagnosis of TB, delays in diagnosis remain a major problem in the clinical practice. Because of the slow growth rate of the causative agent Mycobacterium tuberculosis, isolation, identification, and drug susceptibility testing of this organism and other clinically important mycobacteria can take several weeks or longer. During the past several years, many methods have been developed for direct detection, species identification, and drug susceptibility testing of TB. A good understanding of the effectiveness and practical limitations of these methods is important to improve diagnosis. This review summarizes the currently-used advances in non-molecular and molecular diagnostics.

ICF 한글개정판 개발 (Development of Revised Korean Version of ICF)

  • 이해정;송주민
    • The Journal of Korean Physical Therapy
    • /
    • 제26권5호
    • /
    • pp.344-350
    • /
    • 2014
  • Purpose: The purpose of this study was to translate and culturally adapt the International Classification of Functioning, Disability and Health (ICF) into the Korean language. Methods: The process of translation and adaptation of the ICF used here followed the translation guidelines of WHO. Implementation of this procedure comprised of four steps; forward translation, expert panel back-translation, pre-testing and cognitive interviewing, and final adaptation. The translators included health professionals with knowledge of ICF and non-health professionals blinded to the ICF. Clinical academics with significant experience in the use of disability survey, medical doctors, special educators, related policy makers, clinicians, architecture professionals, and international experts in ICF were invited to integrate all versions of the ICF for testing; 151 clinicians volunteered from 19 medical institutes across the country. Four different core-sets and a questionnaire were used for testing its practical usability and adaptation. Results: All translations were reviewed and a consensus was reached on any discrepancy from the earlier versions. Over 90% of the newly translated version of K-ICF was found to be different from the 2004 K-ICF version in the ICF language. Understanding of K-ICF language was responded difficult and very difficult by 50% of participants, whereas its practical use was responded 'useful' by more than 50% of subjects. Conclusion: It can be suggested that the new version of K-ICF should be widely used for final adaptation in the field of areas. Future studies will be required for implementation of K-ICF.

Guidelines for Manufacturing and Application of Organoids: Lung

  • Kyungtae Lim;Mi-Ok Lee;Jinwook Choi;Jung-Hyun Kim;Eun-Mi Kim;Chang Gyu Woo;Chaeuk Chung;Yong-Hee Cho;Seok-Ho Hong;Young-Jae Cho;Sun-Ju Ahn
    • International Journal of Stem Cells
    • /
    • 제17권2호
    • /
    • pp.147-157
    • /
    • 2024
  • The objective of standard guideline for utilization of human lung organoids is to provide the basic guidelines required for the manufacture, culture, and quality control of the lung organoids for use in non-clinical efficacy and inhalation toxicity assessments of the respiratory system. As a first step towards the utilization of human lung organoids, the current guideline provides basic, minimal standards that can promote development of alternative testing methods, and can be referenced not only for research, clinical, or commercial uses, but also by experts and researchers at regulatory institutions when assessing safety and efficacy.

Distribution and Antifungal Susceptibilities of Candida Species Isolated from Blood Cultures from 2016 to 2023 years

  • Seung Bok Hong
    • 대한의생명과학회지
    • /
    • 제30권2호
    • /
    • pp.73-80
    • /
    • 2024
  • The aim of this study was to investigate the distribution and antifungal susceptibilities of Candida spp. from blood culture to provide useful information on empirical treatment of Candidemia. We investigated distribution and antifungal susceptibilities of Candida spp. isolated from blood culture during an 8-years (2016-2023) in a C-University hospital. Over 8 years, 1,182 Candida strains from blood culture were isolated, which was fourth most common cause of bloodstream infection. Among nonduplicated 350 Candida strains, C. albicans was the most common with 45.43%, followed by C. glabrata (17.43%), C. tropicalis (17.43%), C. parapsilosis (14.86%), C. guilliermondii (1.71%), C. krusei (0.86%), C. lusitaniae (0.86%), C. ciferrii (0.57%). In the antifungal susceptibility testing on 323 Candida strains, the non-susceptibility rate was 2.48% for amphotericin B, 1,71% for flucytosine, 3.09% for fluconazole, 4.66% for voriconazole, 5.57% for caspofungin, and 0.62% for micafungin. In particular, C. albicans showed non-susceptibility of 8.23% to voriconazole, and C. glabrata showed 14.81% and 24.59% to fluconazole and caspofungin, respectively. These data showed that the prevalence of candidemia is very common, and antifungal resistance in Candida spp., especially C. glabrata, is increasing. Therefore, periodic surveillance of prevalence and antifungal susceptibility of blood culture is very important for clinical laboratory.

Pulsed Radiofrequency Treatment of Pain Relieving Point in a Soft Tissue

  • Lee, Jeong-Soo;Yoon, Kyung-Bong;Kim, In-Ki;Yoon, Duck-Mi
    • The Korean Journal of Pain
    • /
    • 제24권1호
    • /
    • pp.57-60
    • /
    • 2011
  • Pulsed radiofrequency (PRF) treatment of nervous tissue has been proposed as a less neurodestructive technique alternative to continuous RF heat lesioning. Recently, clinical reports using PRF have shown favorable effects in the treatment of a variety of focal pain areas, even in non-nervous tissues; however, the mechanism of effect underlying this treatment to non-nervous tissue remains unclear. We report the case of a 67-year-old male who presented with pain reliving point in the posterior neck. The patient had pain in the posterior neck for 3 years. The pain subsided with pressure applied to a point in the posterior neck. There were no specific abnormal findings on laboratory testing and radiologic examinations. After PRF treatment to the pain-relieving point, he had pain relief which lasted more than 5 months.

Proposal on Guideline for Quality Assurance of Radiation Treatment Planning System

  • Oh, Yoonjin;Shin, Dong Oh;Kim, Juhye;Kwon, Nahye;Lee, Soon Sung;Choi, Sang Hyoun;Ahn, Sohyun;Park, Dong-wook;Kim, Dong Wook
    • 한국의학물리학회지:의학물리
    • /
    • 제28권4호
    • /
    • pp.197-206
    • /
    • 2017
  • We develop guidelines for the quality assurance of radiation treatment planning systems (TPS) by comparing and reviewing recommendations from major countries and organizations, as well as by analyzing the AAPM, ESTRO, and IAEA TPS quality assurance guidelines. We establish quality assurance items for acceptance testing, commissioning, periodic testing, system management, and security, and propose methods to perform each item within acceptable standards. Acceptance includes tests of hardware and network environments, data transmission, software, and benchmarking as specified by the system supplier, and apply the IAEA classification criteria. Commissioning includes dosimetric and non-dosimetric items for assessing TPS performance by applying the AAPM classification criteria and the latest technical items from the IAEA. Periodic quality assurance tests include daily, weekly, monthly, yearly, and occasional items by applying the AAPM classification criteria. System management and security items include the state and network connectivity of TPS, periodic data backup, and data access security. The guidelines for TPS quality assurance proposed in this study will help to improve the safety and quality of radiotherapy by preventing incidents related to radiotherapy.

Frequency of EGFR Mutations in Non-small Cell Lung Cancer Patients: Screening Data from West Siberia

  • Gervas, Polina;Ivanova, Anna;Vasiliev, Nikolay;Ananina, Olga;Zharkova, Olga;Rogovieva, Olga;Verzhbitskaya, Natalia;Didichuk, Ivan;Cheremisina, Olga;Popova, Natalia;Goldberg, Victor;Cherdyntsev, Evgeny;Choynzonov, Evgeny;Cherdyntseva, Nadezda
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권2호
    • /
    • pp.689-692
    • /
    • 2015
  • Background: Incorporation of molecular analysis of the epidermal growth factor receptor (EGFR) gene into routine clinical practice has shown great promise to provide personalized therapy of the non-small cell lung cancer (NSCLC) in the developed world. However, the genetic testing of EGFR mutations has not yet become routine clinical practice in territories remote from the central regions of Russia. Therefore, we aimed to study the frequency of major types of activating mutations of the EGFR gene in NSCLC patients residing in West Siberia. Materials and Methods: We examined EGFR mutations in exons 19 and 21 in 147 NSCLC patients (excluding squamous cell lung carcinomas) by real time polymerase chain reaction. Results: EGFR mutations were detected in 28 of the 147 (19%) patients. There were 19 (13%) cases with mutations in exon 19 and 9 cases (6%) in exon 21. Mutations were more frequently observed in women (42%, p=0.000) than in men (1%). A significantly higher incidence of EGFR mutations was observed in bronchioloalveolar carcinomas (28%, p=0.019) and in adenocarcinomas (21%, p=0.024) than in large cell carcinomas, mixed adenocarcinomas, and NOS (4%). The EGFR mutation rate was much higher in never-smokers than in smokers: 38% vs. 3% (p=0.000). The frequency of EGFR mutations in the Kemerovo and Tomsk regions was 19%. Conclusions: The incorporation of molecular analysis of the EGFR gene into routine clinical practice will allow clinicians to provide personalised therapy, resulting in a significant increase in survival rates and improvement in life quality of advanced NSCLC patients.